Drug recall · December 6, 2017
Duloxetine Delayed-Release Capsules USP recall
Why: Failed Dissolution Specification
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Goa 403 722 India, NDC 68180-295-06, UPC 368180295068
- Lots / codes
Lot #: G602051, Exp. 12/2017
- Quantity
- 111,648 units
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Nationwide within the United States
- Initiated
- November 21, 2017 · Voluntary: Firm initiated
- Classified
- November 28, 2017
- Reported
- December 6, 2017
- Ended
- April 15, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Duloxetine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.